Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.22.2
Cover - shares
6 Months Ended
Jun. 30, 2022
Aug. 01, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2022  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 001-39318  
Entity Registrant Name Lantern Pharma Inc.  
Entity Central Index Key 0001763950  
Entity Tax Identification Number 46-3973463  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1920 McKinney Avenue  
Entity Address, Address Line Two 7th Floor  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75201  
City Area Code (972)  
Local Phone Number 277-1136  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol LTRN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,830,947